Search

Search Results

572 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

Page: 1234567891011121314151617181920212223242526272829 of 29

• Research PaperVolume 15, Issue 24pp 15025-15049

  The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis

  Relevance score: 0.00

  Jiaxin Yin, Yuxiao Song, Yang Fu, Wang Jun, Jiazhuo Tang, Zhimin Zhang, Qibin Song, Bicheng Zhang

  Keywords: immune checkpoint inhibitors, non-small cell lung cancer, age, elderly, meta-analysis

  Published in Aging on December 19, 2023

  Show abstract
• Research PaperVolume 15, Issue 17pp 8770-8781

  Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition

  Relevance score: 0.00

  Xiaocui Liang, Shan Zhou, Zefeng Xiao

  Keywords: immune checkpoint inhibitors, uveal melanoma, lactate dehydrogenase, prognosis

  Published in Aging on September 5, 2023

  Show abstract
• Research PaperVolume 14, Issue 6pp 2868-2879

  TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types

  Relevance score: 0.00

  Jia-Zheng Cao, Gao-Sheng Yao, Fei Liu, Yi-Ming Tang, Peng-Ju Li, Zi-Hao Feng, Jun-Hang Luo, Jin-Huan Wei

  Keywords: immune-checkpoint inhibitor therapies, TP53, BRAF, prognosis, precision medicine

  Published in Aging on March 27, 2022

  Show abstract
• Research PaperVolume 15, Issue 18pp 9479-9498

  Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer

  Relevance score: 0.00

  Zheng Gong, Yuming He, Xiao Mi, Chengcheng Li, Xiaoran Sun, Guoqiang Wang, Leo Li, Yusheng Han, Chunwei Xu, Wenxian Wang, Shangli Cai, Liang Wang, Zhongyuan Liu

  Keywords: urothelial cancer, immune checkpoint inhibitor, complement and coagulation cascades, predictive biomarker

  Published in Aging on September 24, 2023

  Show abstract
• Research PaperVolume 15, Issue 16pp 8204-8219

  PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer

  Relevance score: 0.00

  Zhixuan Ren, Li Wang, Chaohui Leng

  Keywords: NSCLC, PTPRD, immune checkpoint inhibitors, nomogram, TCGA

  Published in Aging on August 18, 2023

  Show abstract
• Research PaperVolume 15, Issue 16pp 7997-8012

  HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma

  Relevance score: 0.00

  Liu Li, Kuang Tianrui, Li Chunlei, Qiu Zhendong, Chen Xiaoyan, Deng Wenhong

  Keywords: HYDIN, immune checkpoint inhibitors, melanoma, biomarker, prognosis

  Published in Aging on August 17, 2023

  Show abstract
• ReviewVolume 14, Issue 2pp 1048-1064

  Acquired resistance for immune checkpoint inhibitors in cancer immunotherapy: challenges and prospects

  Relevance score: 0.00

  Xunrui Chen, Wenhui Zhang, Wenyan Yang, Min Zhou, Feng Liu

  Keywords: immunotherapy, acquired resistance, immune checkpoint inhibitor, the tumor microenvironment, combination therapy

  Published in Aging on January 17, 2022

  Show abstract
• Research PaperVolume 12, Issue 11pp 10663-10675

  Association between immune-related adverse events and efficacy of PD-1 inhibitors in Chinese patients with advanced melanoma

  Relevance score: 0.00

  Jing-Jing Zhao, Xi-Zhi Wen, Ya Ding, Dan-Dan Li, Bao-Yan Zhu, Jing-Jing Li, De-Sheng Weng, Xing Zhang, Xiao-Shi Zhang

  Keywords: immune-related adverse events, PD-1 inhibitor, immune checkpoint inhibitors, advanced melanoma, Chinese patients

  Published in Aging on June 8, 2020

  Show abstract
• Research PaperVolume 16, Issue 6pp 5354-5369

  Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients

  Relevance score: 0.00

  Yean Yu, Li Yan, Tianhui Huang, Zhenfu Wu, Juan Liu

  Keywords: cachexia, immune checkpoint inhibitors, cancers, non-small cell lung cancer

  Published in Aging on March 11, 2024

  Show abstract
• Research PaperVolume 15, Issue 24pp 15473-15488

  Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

  Relevance score: 0.00

  Yi-Xin Zhou, Jia-Ling Wang, Xiao-Li Mu, Ya-Juan Zhu, Ye Chen, Ji-Yan Liu

  Keywords: Disitamab Vedotin, immune checkpoint inhibitors, HER2, solid tumors

  Published in Aging on December 22, 2023

  Show abstract
• Research PaperVolume 14, Issue 23pp 9617-9631

  A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

  Relevance score: 0.00

  Yuanjun Cheng, Jie Yao, Qianru Fang, Bin Chen, Guohui Zang

  Keywords: circadian rhythm, immune checkpoint inhibitor, prognosis, lung adenocarcinoma, BARX2

  Published in Aging on December 1, 2022

  Show abstract
• Research PaperVolume 14, Issue 17pp 7170-7185

  A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma

  Relevance score: 0.00

  Jin Liu, Zhao Tan, Shijie Yang, Xinda Song, Wenping Li

  Keywords: circadian rhythm, immune checkpoint inhibitor, prognosis, prostate adenocarcinoma, FBXL22

  Published in Aging on September 13, 2022

  Show abstract
• Research PaperVolume 13, Issue 2pp 2780-2802

  Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer

  Relevance score: 0.00

  Yilin Yan, Zhengnan Huang, Jinming Cai, Pengfei Tang, Fang Zhang, Mingyue Tan, Bing Shen

  Keywords: bladder cancer, immune signature, glycolysis, immune checkpoint inhibitor

  Published in Aging on December 19, 2020

  Show abstract
• Research PaperVolume 15, Issue 10pp 4510-4523

  lncRNA PCBP1-AS1 mediated downregulation of ITGAL as a prognostic biomarker in lung adenocarcinoma

  Relevance score: 0.00

  Qiang Wang, GuangJun Xiao, Na Li, Xiulin Jiang, Chunhong Li

  Keywords: integrin alpha L, immunotherapy, immune checkpoint inhibitors, NSCLC, lncRNA

  Published in Aging on May 31, 2023

  Show abstract
• CorrectionVolume 16, Issue 22pp 13693-13693

  Correction for: PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer

  Relevance score: 0.00

  Zhixuan Ren, Li Wang, Chaohui Leng

  Keywords: NSCLC, PTPRD, immune checkpoint inhibitors, nomogram, TCGA

  Published in Aging on December 31, 2024

• Research PaperVolume 16, Issue 2pp 1516-1535

  Molecular map of cGAS-STING pathway-related genes in bladder cancer: the perspective toward immune microenvironment and prognosis

  Relevance score: 0.00

  Dong Wei, Ying Liu, Ying Yuan, Yishuai Li, Fangchao Zhao, Xuebo Qin

  Keywords: cGAS-STING pathway, bladder cancer, tumor immune, immune microenvironment, immune checkpoint inhibitors

  Published in Aging on January 17, 2024

  Show abstract
• Research PaperVolume 15, Issue 9pp 3538-3548

  m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway

  Relevance score: 0.00

  Zhen Zhang, Xiaoning Tan, Ruoxia Wu, Tianhao Deng, Huazhong Wang, Xiulin Jiang, Puhua Zeng, Junqi Tang

  Keywords: lncRNA, immunotherapy, immune checkpoint inhibitors, T cell exhaustion, cancer stem cell, cisplatin resistance

  Published in Aging on May 3, 2023

  Show abstract
• Research PaperVolume 16, Issue 3pp 2753-2773

  Integrative analysis of single-cell and bulk RNA-sequencing data revealed disulfidptosis genes-based molecular subtypes and a prognostic signature in lung adenocarcinoma

  Relevance score: 0.00

  Haixia Wang, Xuemei Zhu, Fangchao Zhao, Pengfei Guo, Jing Li, Jingfang Du, Guoyong Shan, Yishuai Li, Juan Li

  Keywords: disulfidptosis, lung adenocarcinoma, tumor microenvironment, immune checkpoint inhibitors, chemoradiotherapy

  Published in Aging on February 5, 2024

  Show abstract
• Research PaperVolume 13, Issue 5pp 7199-7210

  APDL1-CART cells exhibit strong PD-L1-specific activity against leukemia cells

  Relevance score: 0.00

  Qunyi Peng, Xiongpeng Zhu, Chuntuan Li, Pengliang Xin, Yan Zheng, Shengquan Liu

  Keywords: leukemia, PD-1/PD-L1, aPDL1-CART cells, MEDI4736, immune checkpoint inhibitor

  Published in Aging on February 26, 2021

  Show abstract
• Research PaperVolume 12, Issue 24pp 25101-25119

  Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker

  Relevance score: 0.00

  Jin Bai, BoWen Yang, Ruichuan Shi, Xinye Shao, Yujing Yang, Fang Wang, Jiawen Xiao, Xiujuan Qu, Yunpeng Liu, Ye Zhang, Zhi Li

  Keywords: immune checkpoint blockade, microtubule inhibitors, mutation, DYNC1H1, gastric cancer

  Published in Aging on November 20, 2020

  Show abstract